Skip to main content
. 2021 Jan 15;60(11):1753–1757. doi: 10.2169/internalmedicine.4916-20

Figure 2.

Figure 2.

Clinical course. The patient received idarubicin and cytarabine as induction therapy and achieved a hematological remission. Leukemia and pancreatitis both improved after chemotherapy, and the abnormal pancreas and kidney findings disappeared after the first course of consolidation chemotherapy. IDR: idarubicin, AraC: cytarabine, HD AraC: high-dose cytarabine, FISH: fluorescence in situ hybridization, mono: monocyte, RNA: ribonucleic acid